Patents by Inventor Steven Charles

Steven Charles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONVERSION OF CINEMA THEATRE TO A SUPER CINEMA THEATRE
    Publication number: 20090262305
    Abstract: Methods of and equipment for converting existing standard motion picture theatres to one having highly immersive, large fields of view are addressed. Aspects of the methods including moving motion picture screens closer to the audience and employing different projection equipment to avoid or minimize appearance of unrealistic or non-natural image artefacts. Alternative sound systems too are detailed.
    Type: Application
    Filed: June 30, 2009
    Publication date: October 22, 2009
    Inventors: STEVEN CHARLES READ, Brian John Bonnick, George Eric Jacques
  • Conversion of cinema theatre to a super cinema theatre
    Patent number: 7595860
    Abstract: Methods of and equipment for converting existing standard motion picture theatres to one having highly immersive, large fields of view are addressed. Aspects of the methods include moving motion picture screens closer to the audience and employing different projection equipment to avoid or minimize appearance of unrealistic or non-natural image artifacts. Alternative sound systems too are detailed, as is placement of various loudspeakers relative to, for example, projection screens or theatre walls.
    Type: Grant
    Filed: July 27, 2006
    Date of Patent: September 29, 2009
    Assignee: IMAX Corporation
    Inventors: Steven Charles Read, Brian John Bonnick, George Eric Jacques
  • VISUAL STATE MANAGER FOR CONTROL SKINNING
    Publication number: 20090219294
    Abstract: Embodiments described herein are directed to automatically generating an animation for a transition between a current state and a new state. In one embodiment, a computer system accesses state properties of a visual element corresponding to a current state the visual element is in and a new state the visual element is to be transitioned to. The state properties include visual properties and transition description information. The computer system determines the differences between the visual properties of the current state and the new state and automatically generates an animation based on the determined differences between the visual properties for the current state and the new state, such that the animation is playable to transition the visual element from the current state to new state.
    Type: Application
    Filed: February 29, 2008
    Publication date: September 3, 2009
    Applicant: Microsoft Corporation
    Inventors: Kenneth L. Young, Steven Charles White, Christian B. Schormann
  • POWER SOURCE HAVING A PARALLEL CELL TOPOLOGY
    Publication number: 20090208824
    Abstract: A power source with multiple cells connected in parallel to a common node or power supply point. The individual cells within the power source may also have a dedicated controller for each of the individual cells such that the dedicated controllers are connected on a one to one basis with each of the respective individual cells.
    Type: Application
    Filed: February 15, 2008
    Publication date: August 20, 2009
    Applicant: Apple, Inc.
    Inventors: Thomas Charles Greening, William Athas, Steven Charles Michalske
  • Emergency Information Access on Portable Electronic Devices
    Publication number: 20090205041
    Abstract: Improved techniques for facilitating emergency access to one or more contacts stored on a portable electronic device are disclosed. One or more contacts on the portable electronic device are designated as emergency contacts. While the portable electronic device is password-locked, a request to display the one or more emergency contacts on the password-locked portable electronic device is received. Without requiring a password, the one or more emergency contacts are displayed on the portable electronic device.
    Type: Application
    Filed: February 8, 2008
    Publication date: August 13, 2009
    Inventor: Steven Charles Michalske
  • NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20090197872
    Abstract: This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their use in the manufacture of pharmaceutical compositions. The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 29, 2007
    Publication date: August 6, 2009
    Inventors: Dan Peters, Gunnar M. Olsen, Elsebet Ostergaard Nielsen, Daniel B. Timmermann, Steven Charles Loechel, Jens Damsgaard Mikkelsen, Henrik Bjork Hansen, John Paul Redrobe, Jeppe Kejser Christensen, Tino Dyhring
  • Cross-platform transportable database
    Patent number: 7571173
    Abstract: A method and apparatus for creating a target database on a target platform based on a source database on a source platform is provided. A target database is created on the target platform based on data, metadata (for example, data in the system tablespace and control files), and external objects (for example, password files and externally stored tables) comprised within the source database. Data and metadata stored in tablespaces of the source database are converted to the format compatible with the target platform. The conversion of the data and metadata may be performed either at the source database or the target database. Redo information and undo information of the source database are not copied from the source database to the target database. Certain files, e.g., a password files, and links to externally stored object may be recreated on the target database.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: August 4, 2009
    Assignee: Oracle International Corporation
    Inventors: Wanli Yang, Bipul Sinha, Amit Ganesh, Wei Hu, Alok Pareek, Alexander H. Hwang, Steven Charles Wertheimer, Francisco M. Sanchez, Dmitry Mikhailovich Potapov, Shen-Ban Meng, Juan R. Loaiza, William H. Bridge, J. William Lee
  • NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONANE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20090186880
    Abstract: This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 21, 2007
    Publication date: July 23, 2009
    Inventors: Dan Peters, Gunnar M. Olsen, Elsebet Ostergaard Nielsen, Daniel B. Timmermann, Steven Charles Loechel, Jeppe Kejser Christensen, Tino Dyhring
  • NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYL PYRIMIDINYL DERIVATIVE AND ITS MEDICAL USE
    Publication number: 20090181984
    Abstract: This invention relates to a novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its use in the manufacture of pharmaceutical compositions. The compound of the invention is found to be a cholinergic ligand at the nicotinic acetylcholine receptors. Due to its pharmacological profile the compound of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 29, 2007
    Publication date: July 16, 2009
    Inventors: Dan Peters, Gunnar M. Olsen, Elsebet Ostergaard Nielsen, Daniel B. Timmermann, Steven Charles Loechel
  • ADVERTISEMENT PRESENTATION AND TRACKING IN A TELEVISION APPARATUS
    Publication number: 20090178079
    Abstract: A system and a method is disclosed which allows both advertisement and program information to be shown on a channel banner, while user changes channel. In another embodiment, an “advertisement channel” is inserted into an active channel list (e.g., scan list), so that when a user is changing channel, a selected ad will be displayed. In yet another embodiment, a method for tracking and collating advertisement display activity in a video system supporting composite display of image data associated with different multimedia functions and advertisements is disclosed.
    Type: Application
    Filed: January 6, 2009
    Publication date: July 9, 2009
    Applicant: THOMSON LICENSING
    Inventors: Mike Arthur Derrenberger, John Frederick Teskey, Thomas Herman Hamilton, Steven Charles Rhoads, Michael Eugene Willcox, Hugh Boyd Morrison, Robert Joseph Logan, Jill Suzanne Allen
  • MOVING PARTICLE DISPLAY DEVICE
    Publication number: 20090160759
    Abstract: A moving particle display device comprises an array of rows and columns of display pixels (41,42,43,44), a plurality of row address lines (Row1,Row2;72; 112), each row address line for addressing a respective row of pixels and a plurality of column address lines (Col1,Col2;76; 108), each for providing pixel data to a respective column of pixels. A plurality of discharge column lines (82) is provided. A pixel is addressed by addressing a row of pixels and providing data to the pixels in the addressed row using the column address lines (Col1,Col2;76; 108). A charge flow from a column address line to an addressed pixel in the column flows to a respective discharge column line (82). By having discharge lines in the column direction, when a row of pixels is addressed, a current flow through the pixel, which is used to load data into the pixel from a column address line, passes to a column discharge line.
    Type: Application
    Filed: May 10, 2007
    Publication date: June 25, 2009
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Steven Charles Deane, Ian French
  • DISPLAY DEVICE
    Publication number: 20090160846
    Abstract: A system for driving a moving particle display device, such as an electrophoretic display device, is disclosed. The display device comprises first and second cells (30) that are set to target optical states to give the cells' their target optical appearances. The first and second cells are driven differently from one another, such that errors in the first cell's target optical state occur in the opposite direction to errors in the second cell's target optical state. Hence, when the cells are viewed from a distance by a viewer of the display, the light from the first and second cells mixes together, and the optical state errors appear to compensate or cancel one another out.
    Type: Application
    Filed: May 9, 2007
    Publication date: June 25, 2009
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventor: Steven Charles Deane
  • Tropane compounds
    Publication number: 20090163471
    Abstract: A compound according to Formula I or II: wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: October 27, 2008
    Publication date: June 25, 2009
    Inventors: Kenneth D. Rice, Naing Aay, Neel Kumar Anand, Arlyn Arcalas, Tae-Gon Baik, Charles M. Blazey, Owen Joseph Bowles, Chris A. Buhr, Joerg Bussenius, Simona Costanzo, Jeffrey Kimo Curtis, Steven Charles Defina, Larisa Dubenko, Abigail R. Kennedy, Angie Inyoung Kim, Katherine Lara, Sunghoon Ma, Jean-Claire Limun Manalo, Csaba J. Peto, Tsze H. Tsang, Longcheng Wang
  • Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
    Publication number: 20090156576
    Abstract: Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.
    Type: Application
    Filed: October 5, 2006
    Publication date: June 18, 2009
    Applicant: EXELIXIS INC.
    Inventors: Naing Aay, Neel Kumar Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Kimo Curtis, Steven Charles DeFina, Larisa Dubenko, Anagha Abhijit Joshi, Abigail R. Kennedy, Angie Inyoung Kim, Elena S. Koltun, Jean-Claire Limun Manalo, Csaba J. Peto, Kenneth D. Rice, Tsze H. Tsang
  • System and method for generating interpreted damage estimates information
    Publication number: 20090150200
    Abstract: A method and system for generating interpreted damage estimate information. The steps of generating an interpretation of repair operations consists of selecting a interpretation template from a plurality of interpretation templates, reading a damage estimate file, identifying one or more nomenclature in said damage estimate containing repair operations, determining the sections or groups' contained in said damage estimate file, identifying common section indices for the identified sections or groups, retrieving repair/refinish/replacement parts interpretations that consist of a common section index, related repair/refinish/replacement interpretation, interpreted section header, associated graphical images, and creating a displayable repair interpretation file.
    Type: Application
    Filed: December 9, 2008
    Publication date: June 11, 2009
    Inventor: Steven Charles Siessman
  • METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSION
    Publication number: 20090142320
    Abstract: Disclosed in this specification is a method to promote the growth of CD4+CD25Foxp3+ nTreg cells in a culture while minimizing the production of IL-17. The resulting cells are useful in the treatment of immune-related diseases.
    Type: Application
    Filed: February 3, 2009
    Publication date: June 4, 2009
    Inventors: TingHua Cao, Steven Charles Eck, Li Li
  • METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
    Publication number: 20090142318
    Abstract: Disclosed in this specification is a method to promote the growth of CD4+CD25Foxp3+ nTreg cells in a culture while treating the culture with a p70 S6 kinase inhibitor. The resulting cells are useful in the treatment of immune-related diseases.
    Type: Application
    Filed: February 3, 2009
    Publication date: June 4, 2009
    Inventors: Steven Charles Eck, Li Li
  • METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST
    Publication number: 20090142319
    Abstract: Disclosed in this specification is a method to promote the growth of CD4+CD25Foxp3+ nTreg cells in a culture while treating with a PI-3K antagonist. The resulting cells are useful in the treatment of immune-related diseases.
    Type: Application
    Filed: February 3, 2009
    Publication date: June 4, 2009
    Inventors: Steven Charles Eck, Li Li
  • NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONANE DERIVATIVES AND THEIR MEDICAL USE
    Publication number: 20090118265
    Abstract: This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 21, 2007
    Publication date: May 7, 2009
    Inventors: Dan Peters, Gunnar M. Olsen, Elsebet Ostergaard Nielsen, Daniel B. Timmermann, Steven Charles Loechel, Jeppe Kejser Christensen, Tino Dyhring
  • Glasses
    Patent number: D596659
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: July 21, 2009
    Assignee: Imax Corporation
    Inventors: Paul Kucera, Steven Charles Read, Simon Treadwell